CAS RN: 865792-18-3

Cilostazol Related Compound C (50 mg) (1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one)

Product Availability

Available package options are listed below.

1 package records0 with current stock
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20250501 100mg Out of stock 15 business days Inquiry
  • Product code: starshine_CAS865792-18-3
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

865792-18-3 / 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyltetrazol-5-yl)butyl]-3,4-dihydroquinolin-2-one

Standard CAS: 865792-18-3 Multi CAS: No

Basic Information

CAS
865792-18-3
Multi CAS
No
Molecular Formula
C31H45N9O2
Molecular Weight
575.700000
Exact Mass
575.369622
InChI
InChI=1S/C31H45N9O2/c41-31-20-17-24-23-27(42-22-10-8-16-30-33-35-37-40(30)26-13-5-2-6-14-26)18-19-28(24)38(31)21-9-7-15-29-32-34-36-39(29)25-11-3-1-4-12-25/h18-19,23,25-26H,1-17,20-22H2
InChIKey
GVMLJEUDNKNZAH-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
42
Aromatic heavy atom count
16
Fraction Csp3
0.71
Rotatable bonds
13
H-bond acceptors
10
Molar refractivity
158.36
TPSA
116.74

LogP / Solubility

WLOGP
5.37
MLOGP
4.77
XLogP3
5.3
Consensus LogP
5.15
Log S (ESOL)
-6.22
Class (ESOL)
Insoluble
Log S (Ali)
-8.16
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-9.42
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.42

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
Yes
Muegge
No
Bioavailability score
0.56
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
5.5

Get In Touch

Contact Us